Table 1.
Clinical data of patients.
| General data | |
|---|---|
| Age (years old) | 67.7 ± 4.8 |
| Gender (male/female) | 10/1 |
| Past history [n (%)] | |
| Smoking | 10 (91.1) |
| Hypertension | 7 (63.7) |
| Diabetes | 3 (27.3) |
| COPD | 7 (63.7) |
| Idiopathtic pulmonary fibrosis | 1 (8.9) |
| Maximum diameter of lesion (cm) (range) | 5.7 ± 1.4 (3.2–8.2) |
| Lesion site [n (%)] | |
| Left upper lobe | 4 (36.3) |
| Left lower lobe | 2 (18.2) |
| Right upper lobe | 3 (27.3) |
| Right lower lobe | 2 (18.2) |
| Pathological type [n (%)] | |
| adenocarcinoma | 1 (8.9) |
| squamous carcinoma | 10 (91.1) |
| Pathological stage [n (%)] | |
| IIIA | 6 (54.6) |
| IIIB | 5 (45.4) |
| PD-L1 expression level | |
| <1% | 3 (27.3) |
| ≥1% | 4 (36.3) |
| unknown | 4 (36.3) |
| FEV1% | |
| Mean ± SD (range) | 77.2 ± 9.1 (55–95) |
| EGFR mutational status [n (%)] | 0 |
| ALK mutational status [n (%)] | 0 |
| Surgical method | |
| VATS | 10 (91.1) |
| Thoracotomy | 1 (8.9) |